Monthly Archives: February 2012

Why 60 Minutes suddenly discovered the placebo effect in treating depression

Share When Dr. Irving Kirsch published his meta-analysis in PLoS Medicine in February 2008 showing that antidepressants were no more effective than a placebo in treating mild or moderate depression, the national news media ignored his explosive findings, for the … Continue reading

Posted in antidepressants, conflicts of interest, drug marketing, health care costs, pharmaceutical industry | Tagged , , , , | 16 Comments

When it comes to scientific misconduct, should there be a statute of limitations?

Share I was hesitant to weigh in at first when I learned that Brown University’s School of Medicine had decided not to pressure a psychiatric journal to retract the seriously flawed Paxil study that I wrote about in Side Effects. … Continue reading

Posted in antidepressants, clinical trials, conflicts of interest, FDA, ghostwriting, pharmaceutical industry, scientific journal retractions, scientific misconduct | 7 Comments